BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28751233)

  • 1. Sputum autoantibodies in patients with severe eosinophilic asthma.
    Mukherjee M; Bulir DC; Radford K; Kjarsgaard M; Huang CM; Jacobsen EA; Ochkur SI; Catuneanu A; Lamothe-Kipnes H; Mahony J; Lee JJ; Lacy P; Nair PK
    J Allergy Clin Immunol; 2018 Apr; 141(4):1269-1279. PubMed ID: 28751233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
    Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody-mediated Macrophage Dysfunction in Patients with Severe Asthma with Airway Infections.
    Son K; Miyasaki K; Salter B; Loukov D; Chon J; Zhao N; Radford K; Huang C; LaVigne N; Dvorkin-Gheva A; Lacy P; Ho T; Bowdish DME; Nair P; Mukherjee M
    Am J Respir Crit Care Med; 2023 Feb; 207(4):427-437. PubMed ID: 36287613
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.
    Mukherjee M; Aleman Paramo F; Kjarsgaard M; Salter B; Nair G; LaVigne N; Radford K; Sehmi R; Nair P
    Am J Respir Crit Care Med; 2018 Jan; 197(1):38-46. PubMed ID: 28915080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway autoantibodies are determinants of asthma severity.
    Salter B; Zhao N; Son K; Tan NS; Dvorkin-Gheva A; Radford K; LaVigne N; Huang C; Kjarsgaard M; Li QZ; Tselios K; Lim HF; Khalidi N; Nair P; Mukherjee M
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35777765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J; Jiang F; Nayeri F; Zetterström O
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5.
    Moermans C; Brion C; Bock G; Graff S; Gerday S; Nekoee H; Poulet C; Bricmont N; Henket M; Paulus V; Guissard F; Louis R; Schleich F
    Chest; 2023 Jun; 163(6):1368-1379. PubMed ID: 36740095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
    Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.
    Nair P; Ochkur SI; Protheroe C; Radford K; Efthimiadis A; Lee NA; Lee JJ
    Allergy; 2013 Sep; 68(9):1177-84. PubMed ID: 23931643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
    Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia.
    Smith SG; Chen R; Kjarsgaard M; Huang C; Oliveria JP; O'Byrne PM; Gauvreau GM; Boulet LP; Lemiere C; Martin J; Nair P; Sehmi R
    J Allergy Clin Immunol; 2016 Jan; 137(1):75-86.e8. PubMed ID: 26194544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Klein DK; Silberbrandt A; Frøssing L; Hvidtfeldt M; von Bülow A; Nair P; Mukherjee M; Porsbjerg C
    Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35236724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects.
    Sánchez J; Sánchez Biol A; Múnera Biol M; García E; López JF
    World Allergy Organ J; 2023 Feb; 16(2):100742. PubMed ID: 36941898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
    Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sputum hyaluronan and versican in severe eosinophilic asthma.
    Ayars AG; Altman LC; Potter-Perigo S; Radford K; Wight TN; Nair P
    Int Arch Allergy Immunol; 2013; 161(1):65-73. PubMed ID: 23257685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new compound, 1H,8H-pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma.
    Lee H; Han AR; Kim Y; Choi SH; Ko E; Lee NY; Jeong JH; Kim SH; Bae H
    Int J Immunopathol Pharmacol; 2009; 22(3):591-603. PubMed ID: 19822076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for severe eosinophilic asthma.
    Yancey SW; Keene ON; Albers FC; Ortega H; Bates S; Bleecker ER; Pavord I
    J Allergy Clin Immunol; 2017 Dec; 140(6):1509-1518. PubMed ID: 29221581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.
    Mukherjee M; Forero DF; Tran S; Boulay ME; Bertrand M; Bhalla A; Cherukat J; Al-Hayyan H; Ayoub A; Revill SD; Javkar T; Radford K; Kjarsgaard M; Huang C; Dvorkin-Gheva A; Ask K; Olivenstein R; Dendukuri N; Lemiere C; Boulet LP; Martin JG; Nair P
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32444405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.
    Strauss RA; Jawhari N
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):121-123. PubMed ID: 29684570
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
    Kulkarni NS; Hollins F; Sutcliffe A; Saunders R; Shah S; Siddiqui S; Gupta S; Haldar P; Green R; Pavord I; Wardlaw A; Brightling CE
    J Allergy Clin Immunol; 2010 Jul; 126(1):61-9.e3. PubMed ID: 20639010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.